Bienaime Jean Jacques
- SEC CIK
- 0001221590
In the past year, 12 open-market purchase filings worth $1.13M and 1 sale filing worth $203.8K.
Current role at each company
- ASND Ascendis Pharma A/SDirectoras of Sep 28, 2026
- KROS Keros Therapeutics, Inc.Directoras of Aug 19, 2026
- IMNM Immunome Inc.Directoras of Jun 12, 2026
- INCY Incyte CorpDirectoras of Jun 10, 2026
- BMRN Biomarin Pharmaceutical IncDirectoras of May 21, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.13M
- 12 filings
- Sold
- $203.8K
- 1 filing
- Net
- +$922.7K
- Bought minus sold
- Companies
- 3
- With open-market trades
Trades
Every Form 4 that lists Bienaime Jean Jacques as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KROS Keros Therapeutics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Bienaime Jean JacquesDirector | PPurchase | +2.00K | $11.21 | +$22.4K | +36.7%7.45K after | 10b5-1 |
| Apr 17, 2026 (view filing) | Apr 15 | 2 days | Bienaime Jean JacquesDirector | PPurchase | +1.00K | $11.70 | +$11.7K | +13.4%8.45K after | 10b5-1 |
| May 19, 2026 (view filing) | May 15 | 4 days | Bienaime Jean JacquesDirector | PPurchase | +1.00K | $10.58 | +$10.6K | +11.8%9.45K after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Bienaime Jean JacquesDirector | PPurchase | +1.00K | $10.19 | +$10.2K | +6.0%17.6K after | 10b5-1 |
| Jul 17, 2026 (view filing)4:10 PM ET | Jul 15 | 2 days | Bienaime Jean JacquesDirector | PPurchase | +1.00K | $10.61 | +$10.6K | +5.7%18.6K after | 10b5-1 |
| Aug 19, 2026 (view filing)4:10 PM ET | Aug 17 | 2 days | Bienaime Jean JacquesDirector | PPurchase | +1.00K | $10.27 | +$10.3K | +5.4%19.6K after | 10b5-1 |
ASND Ascendis Pharma A/S
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 (view filing) | May 26 | 1 day | Bienaime Jean JacquesDirector | PPurchase | +400 | $237.81 | +$95.1K | New position400 after | 2 lots |
| Jun 1, 2026 (view filing) | May 29 | 3 days | Bienaime Jean JacquesDirector | PPurchase | +500 | $223.12 | +$111.6K | +125.0%900 after | 3 lots |
| Aug 18, 2026 (view filing)9:02 PM ET | Aug 14 | 4 days | Bienaime Jean JacquesDirector | PPurchase | +2.00K | $246.33 | +$492.7K | +222.2%2.90K after | 2 lots |
IMNM Immunome Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 (view filing) | May 21 | 1 day | Bienaime Jean JacquesDirector | PPurchase | +2.00K | $13.57 | +$27.1K | +26.3%9.62K after | |
| Aug 19, 2024 (view filing) | Aug 16 | 3 days | Bienaime Jean JacquesDirector | PPurchase | +7.00K | $13.94 | +$97.6K | +72.8%16.6K after | |
| Mar 25, 2025 (view filing) | Mar 24 | 1 day | Bienaime Jean JacquesDirector | PPurchase | +7.00K | $8.21 | +$57.5K | +42.1%23.6K after | |
| Mar 26, 2025 (view filing) | Mar 25 | 1 day | Bienaime Jean JacquesDirector | PPurchase | +7.80K | $7.78 | +$60.7K | +33.0%31.4K after | |
| Jun 3, 2025 (view filing) | Jun 3 | Same day | Bienaime Jean JacquesDirector | PPurchase | +5.00K | $9.38 | +$46.9K | +15.9%36.4K after | |
| Mar 12, 2026 (view filing) | Mar 10-11 | 2 days | Bienaime Jean JacquesDirector | PPurchase | +2.00K | $21.84 | +$43.7K | +5.5%38.4K after | 2 lots |
| May 19, 2026 (view filing) | May 15 | 4 days | Bienaime Jean JacquesDirector | PPurchase | +5.00K | $20.70 | +$103.5K | +13.0%43.4K after | |
| Jun 9, 2026 (view filing) | Jun 5 | 4 days | Bienaime Jean JacquesDirector | SSale | −10.5K | $19.41 | −$203.8K | −24.2%32.9K after | 2 lots |
| Jun 9, 2026 (view filing) | Jun 5 | 4 days | Bienaime Jean JacquesDirector | PPurchase | +10.5K | $19.45 | +$204.3K | +31.9%43.4K after | 3 lots |
BMRN Biomarin Pharmaceutical Inc
Director28 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 (view filing) | Dec 1 | 1 day | Bienaime Jean JacquesChief Executive Officer | SSale | −1.50K | $87.22 | −$130.8K | −0.5%304.4K after | |
| Dec 17, 2021 (view filing) | Dec 15-16 | 2 days | Bienaime Jean JacquesChief Executive Officer | SSale | −12.0K | $83.70 | −$1.00M | −3.8%303.7K after | 2 lots |
| Jan 14, 2022 (view filing) | Jan 12-13 | 2 days | Bienaime Jean JacquesChief Executive Officer | SSale | −10.0K | $88.43 | −$884.3K | −3.2%303.8K after | 2 lots |
| Mar 14, 2022 (view filing) | Mar 10-11 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −30.0K | $77.69 | −$2.33M | −8.1%338.6K after | 2 lots |
| Apr 18, 2022 (view filing) | Apr 14 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −10.0K | $83.66 | −$836.6K | −2.9%335.0K after | |
| Apr 20, 2022 (view filing) | Apr 18 | 2 days | Bienaime Jean JacquesChief Executive Officer | SSale | −20.0K | $81.91 | −$1.64M | −5.6%335.0K after | |
| May 2, 2022 (view filing) | Apr 28-29 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −25.0K | $83.42 | −$2.09M | −6.9%335.0K after | 2 lots |
| May 9, 2022 (view filing) | May 5-6 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −30.0K | $82.05 | −$2.46M | −8.2%335.3K after | 2 lots |
| Aug 16, 2022 (view filing) | Aug 12-15 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −7.00K | $94.95 | −$664.6K | −2.1%328.3K after | 2 lots |
| Oct 18, 2022 (view filing) | Oct 14 | 4 days | Bienaime Jean JacquesChief Executive Officer | SSale | −4.00K | $89.89 | −$359.6K | −1.2%324.3K after |